← All articles

stem-cell-therapy

Clinical applications of stem cells to repair, replace, or regenerate damaged tissues and treat disease.

5 articles

Breaking Bad Orthopedics: Escaping the Cycle of Reactive Care with Regenerative Medicine
Blog
1 min read
Breaking Bad Orthopedics: Escaping the Cycle of Reactive Care with Regenerative Medicine
On the Future Proof with Forever Labs podcast, Drs. Tad DeWald and Brett Fox talk about proactive prehab and regenerative medicine. They promote a 50/50 partnership between clinical care and personal movement to future-proof your physical health.
OrthopedicOsteoarthritisMesenchymal stem cellsTissue renewalstem-cell-therapy
2026: The Year of Longevity and Owning your Biology
Blog
1 min read
2026: The Year of Longevity and Owning your Biology
Explore Forever Labs's outlook on 2026 trends in regenerative medicine. Longevity has transitioned from biohacking to a mainstream standard of care. Discover breakthroughs in "bio-liquidity", MSC priming, and epigenetic resetting, alongside regulatory shifts in the United States empowering patients to own their biology.
blogAutologous Stem CellsAgingstem-cell-therapyMesenchymal stem cells
Role of Insulin-like Growth Factor 1 Receptor Signaling in Stem Cell Stemness and Therapeutic Efficacy
Clinical
1 min read
Pmc
Role of Insulin-like Growth Factor 1 Receptor Signaling in Stem Cell Stemness and Therapeutic Efficacy
New research highlights the critical role of insulin-like growth factor 1 receptor (IGF1R) in enhancing stem cell self-renewal and therapeutic potential. Understanding IGF1R signaling could significantly improve regenerative treatments, making stem cell preservation more valuable for future health needs.
Insulin Like Growth Factor 1 ReceptorNeuroprotectionCardiac Regenerationstem-cell-therapy
AI generated image for: Florida HB 1617 - Stem Cell Therapy Authorization
Regulatory
1 min read
Florida Legislature
Florida HB 1617 - Stem Cell Therapy Authorization
Florida HB 1617 authorizes physicians to perform FDA-unapproved stem cell therapy with specific requirements for manufacturing practices, patient consent, and advertising disclosures. Effective July 1, 2025.
regulatorystem-cell-therapy

Explore more topics